Dawn of a new indication: How to study drugs for aging
Professor Ilaria Bellantuono, Co-Director of the University of Sheffield's Healthy Lifespan Institute, discusses her research into medicines for frailty, and why she believes labelling aging as a disease indication could have negative consequences.
| Published by Pharmaceutical Technology